Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

被引:82
|
作者
Lee, Alexandra K. [1 ,2 ]
Lee, Clare J. [3 ]
Huang, Elbert S. [4 ]
Sharrett, A. Richey [1 ,2 ]
Coresh, Josef [1 ,2 ]
Selvin, Elizabeth [1 ,2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[4] Univ Chicago Med, Sect Internal Med, Chicago, IL USA
基金
美国国家卫生研究院; 美国医疗保健研究与质量局;
关键词
PREDICTS SEVERE HYPOGLYCEMIA; TIGHT GLYCEMIC CONTROL; QUALITY-OF-LIFE; OLDER-ADULTS; INSULIN SENSITIVITY; MELLITUS; TRIAL; COMPLICATIONS; ASSOCIATION; DEMENTIA;
D O I
10.2337/dc17-0819
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Severe hypoglycemia is a rare but important complication of type 2 diabetes. Few studies have examined the epidemiology of hypoglycemia in a community-based population. RESEARCH DESIGN AND METHODS We included 1,206 Atherosclerosis Risk in Communities (ARIC) Study participants with diagnosed diabetes (baseline: 1996-1998). Severe hypoglycemic events were identified through 2013 by ICD-9 codes from claims for hospitalizations, emergency department visits, and ambulance use. We used Cox regression to evaluate risk factors for severe hypoglycemia. RESULTS The mean age of participants was 64 years, 32% were black, and 54% were female. During a median follow-up period of 15.2 years, there were 185 severe hypoglycemic events. Important risk factors after multivariable adjustment were as follows: age (per 5 years: hazard ratio [HR] 1.24; 95% CI 1.07-1.43), black race (HR 1.39; 95% CI 1.02-1.88), diabetes medications (any insulin use vs. no medications: HR 3.00; 95% CI 1.71-5.28; oral medications only vs. no medications: HR 2.20; 95% CI 1.28-3.76), glycemic control (moderate vs. good: HR 1.78; 95% CI 1.11-2.83; poor vs. good: HR 2.62; 95% CI 1.67-4.10), macroalbuminuria (HR 1.95; 95% CI 1.23-3.07), and poor cognitive function (Digit Symbol Substitution Test z score: HR 1.57; 95% CI 1.33-1.84). In an analysis of nontraditional risk factors, low 1,5-anhydroglucitol, difficulty with activities of daily living, Medicaid insurance, and antidepressant use were positively associated with severe hypoglycemia after multivariate adjustment. CONCLUSIONS Poor glycemic control, glycemic variability as captured by 1,5-anhydroglucitol, kidney damage, and measures of cognitive and functional impairments were strongly associated with increased risk of severe hypoglycemia. These factors should be considered in hypoglycemia risk assessments when individualizing diabetes care for older adults.
引用
收藏
页码:1661 / 1667
页数:7
相关论文
共 50 条
  • [31] Risk Factors For Diabetic Foot Infection: The Atherosclerosis Risk In Communities (ARIC) Study
    Fang, Michael
    Hu, Jiaqi
    Matsushita, Kuni
    Selvin, Elizabeth
    Hicks, Caitlin W.
    CIRCULATION, 2022, 145
  • [32] Progression of Hyperglycemia in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
    Rooney, Mary R.
    Rawlings, Andreea
    Pankow, James S.
    Tcheugui, Justin Echouffo
    Coresh, Josef
    Sharrett, A. Richey
    Selvin, Elizabeth
    CIRCULATION, 2020, 141
  • [33] Age of Diabetes Diagnosis and Lifetime Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study
    Hu, Jiaqi
    Pike, James R.
    Lutsey, Pamela L.
    Sharrett, A. Richey
    Wagenknecht, Lynne E.
    Hughes, Timothy M.
    Seegmiller, Jesse C.
    Gottesman, Rebecca F.
    Mosley, Thomas H.
    Selvin, Elizabeth
    Fang, Michael
    Coresh, Josef
    DIABETES CARE, 2024, 47 (09)
  • [34] Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study
    Hu, Jiaqi
    Fang, Michael
    Pike, James R.
    Lutsey, Pamela L.
    Sharrett, A. Richey
    Wagenknecht, Lynne E.
    Hughes, Timothy M.
    Seegmiller, Jesse C.
    Gottesman, Rebecca F.
    Mosley, Thomas H.
    Coresh, Josef
    Selvin, Elizabeth
    DIABETOLOGIA, 2023, 66 (08) : 1442 - 1449
  • [35] Alcohol consumption and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) study
    Xintong He
    Casey M. Rebholz
    Natalie Daya
    Mariana Lazo
    Elizabeth Selvin
    Diabetologia, 2019, 62 : 770 - 778
  • [36] Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study
    Schneider, A. L. C.
    Lazo, M.
    Ndumele, C. E.
    Pankow, J. S.
    Coresh, J.
    Clark, J. M.
    Selvin, E.
    DIABETIC MEDICINE, 2013, 30 (08) : 926 - 933
  • [37] Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study
    Chatterjee, Ranee
    Yeh, Hsin-Chieh
    Shafi, Tariq
    Anderson, Cheryl
    Pankow, James S.
    Miller, Edgar R.
    Levine, David
    Selvin, Elizabeth
    Brancati, Frederick L.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (05): : 1087 - 1091
  • [38] Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study
    Jiaqi Hu
    Michael Fang
    James R. Pike
    Pamela L. Lutsey
    A. Richey Sharrett
    Lynne E. Wagenknecht
    Timothy M. Hughes
    Jesse C. Seegmiller
    Rebecca F. Gottesman
    Thomas H. Mosley
    Josef Coresh
    Elizabeth Selvin
    Diabetologia, 2023, 66 : 1442 - 1449
  • [39] Alcohol consumption and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) study
    He, Xintong
    Rebholz, Casey M.
    Daya, Natalie
    Lazo, Mariana
    Selvin, Elizabeth
    DIABETOLOGIA, 2019, 62 (05) : 770 - 778
  • [40] Proteomics of Incident Diabetes in Midlife: The Atherosclerosis Risk in Communities (ARIC) Study
    Rooney, Mary R.
    Chen, Jingsha
    Tang, Olive
    Ballantyne, Christie M.
    Boerwinkle, Eric
    Tcheugui, Justin Echouffo
    Ndumele, Chiadi E.
    Demmer, Ryan
    Pankow, James S.
    Lutsey, Pamela
    Wagenknecht, Lynne E.
    Grams, Morgan
    Selvin, Elizabeth
    Coresh, Josef
    DIABETES, 2022, 71